(Q46533539)

English

The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX.

scientific article published on 18 June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Richard Bruggeman

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

B Wilffert

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A F Y Al Hadithy

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

V J Sing

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

G Matroos

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J R B J Brouwers

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P N van Harten

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

0 references

publication date

18 June 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Journal of Psychopharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

652-659

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18562401%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Pharmacogenomics in schizophrenia: the quest for individualized therapy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Comparative Doses and Costs of Antipsychotic Medication

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Ethnicity and antipsychotic response

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene ⋆

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Tardive Dyskinesia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

No correlation between A(-1438)G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Tardive dyskinesia and DRD2, DRD3, DRD4, 5-HT2A variants in schizophrenia: an association study with repeated assessment

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: a preliminary finding

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Clinical potential of respirable antisense oligonucleotides (RASONs) in asthma

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Ethnicity and the course of tardive dyskinesia in outpatients presenting to the motor disorders clinic at the Maryland psychiatric research center

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Familial occurrence of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1177%2F0269881108091594

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46533539&oldid=1407058569"